Aclaris Therapeutics Earnings
NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.83+0.04 (+1.06%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.16
Aclaris Therapeutics earnings summary
Aclaris Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.16.
Summary generated from market data by MetaCap's automated system. Methodology